A new diagnostic drug is being developed to identify abnormal stem cells that cause diabetes. This could provide greater accuracy than traditional diagnostic methods, such as fasting blood sugar levels and Hemoglobin A1C (HbA1C) values.
KIYAN Group and Collaborating Research Institutions
Biozipcode, Inc.
We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).
Learn More About Us
Contact Us
Biozipcode, Inc.
TEL:
+81-50-5534-7865
E-MAIL:
info@biozipcode.com
ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121
© Copyright 2024 Biozipcode, Inc. All Rights Reserved.